10
October 2024
THG PLC
Third quarter trading
statement for the period ended 30 September 2024
Continuing Q3 revenue of
£433.1m (-0.6% CCY)
Growth in Beauty and
Ingenuity with improving trends in Nutrition through the
quarter
Full-year performance
expected to be within the company consensus range
Submission of THG's
notification to the FCA for inclusion in the Equity Shares
(Commercial Companies) ("ESCC") category
Q3
2024 Group Trading Performance
£m
|
Q3
2024
|
YoY[1]
change
|
CCY[2]
change
|
YTD
2024
|
YoY
change
|
CCY
change
|
THG Beauty
|
254.7
|
+2.3%
|
+2.8%
|
775.0
|
+5.2%
|
+7.3%
|
THG Nutrition
|
134.5
|
-13.1%
|
-10.5%
|
434.3
|
-11.6%
|
-7.4%
|
THG Ingenuity (external)
|
44.0
|
+15.0%
|
+16.0%
|
124.2
|
+13.5%
|
+16.0%
|
Group (continuing) revenue
|
433.1
|
-2.0%
|
-0.6%
|
1,333.5
|
-0.3%
|
+2.7%
|
Discontinued revenue
|
9.7
|
-61.3%
|
-61.0%
|
43.3
|
-56.2%
|
-55.3%
|
Total revenue
|
442.8
|
-5.2%
|
-3.9%
|
1,376.8
|
-4.1%
|
-1.3%
|
|
|
|
|
|
|
|
THG Ingenuity (internal)
|
98.9
|
-15.7%
|
-15.7%
|
324.6
|
-11.4%
|
-11.4%
|
THG Ingenuity total
|
142.9
|
-8.2%
|
-8.0%
|
448.7
|
-5.7%
|
-5.2%
|
All comparative figures are continuing CCY unless
otherwise stated.
· Continued growth in
THG Beauty and THG Ingenuity (external), with improving trends in
THG Nutrition during the quarter.
· Solid
performance in THG Beauty as it builds to peak trading with advent
calendar order run rate materially higher YoY.
o Performance in the UK (over half of online Beauty revenue) was
notably strong with active customers in growth (+5%).
o Lookfantastic also launched its first flagship retail store as
part of its targeted omnichannel strategy to enhance brand
awareness, customer appeal and aid product discovery.
· Nutrition YoY revenue performance improved each month through
the quarter.
o Sales have recovered from July and improved steadily through
the quarter as the effect from the Myprotein rebrand fades, with
September marking the second-best sales performance of the year,
finishing the month in online growth excluding Asia.
o Offline revenue growth of +17% in the quarter supports our
expectations of c.25% of total brand sales coming from offline
channels over the medium-term.
o The
transitionary impact from the rebrand is now behind
Myprotein.
o Licencing highlights include the launch of co-branded
Müller dairy products in major UK and
Ireland supermarkets in September, with a complete nutrition
ready-to-drink product also available later this month.
· THG
Ingenuity external revenue growth driven by existing and new
partnerships mainly within fulfilment and courier management
services.
o Monthly recurring revenue[3] for THG
Ingenuity (external) continued to build in September at +44.9% YoY,
an acceleration on September 2023 (+7.6% YoY).
o Onboarding of CDS Superstores (trading as wilko and The Range)
and MySale complete with first dispatches in the quarter. Delivery
options have already been expanded for both clients enhancing their
customer proposition.
o Fulfilment efficiency is expected to improve further for peak
trading this year with the addition of Goods-To-Person robotics at
the Group's Omega distribution centre enabling faster dispatch
times.
· As part
of the Group's ongoing portfolio management to further streamline
all three businesses and optimise margin and cash generation,
certain THG Beauty territories and non-core services were
discontinued during Q3. Please
refer to the appendix for the previous quarter
comparatives.
ESCC transfer
· The
Company's initial notification and eligibility letter for transfer
to the ESCC category has been submitted to the FCA (1st
October 2024). The Company continues to target effecting the
transfer this calendar year and to be included in the FTSE UK Index
reclassification in March 2025.
Outlook and guidance
· As noted in
THG's Interim Results published on 17 September 2024, the second
half of the year remains the Group's most profitable and cash
generative period with the Board expecting full-year performance to
be within the company consensus range[4].
· Seasonal weighting and continued revenue growth in Beauty and
Ingenuity gives us confidence in the outturn, albeit we continue to
monitor FX movements (Japanese Yen c.£7m ytd impact) and rising
whey prices.
Matthew Moulding, CEO of THG commented:
"Today we have separately announced significant progress on
our strategy to demerge THG Ingenuity into a private company
supported by major shareholders. THG PLC will remain a listed
leading consumer brands group, with our planned transfer to the
ESCC well on track.
"It was especially pleasing to see another solid quarter of
delivery from both our Beauty and Ingenuity businesses, rewarding
the significant overhaul of their respective operating models
during 2022 and 2023. The short-term disruption from the major
rebrand of Myprotein is now behind us, and we were pleased that in
September Nutrition delivered its best sales performance since
January.
"We are also proud to be recognised in the top 250 companies
worldwide for our contribution and efforts in sustainability thanks
to our ongoing progress towards our net zero
goals.
"Preparations for our busiest trading period are well advanced
with efficiencies across the network over the last twelve months
delivering further benefits for our Ingenuity clients to aid new
customer acquisition."
Analyst and Institutional investor
conference call
THG will host a conference call for
analysts and institutional investors at 9:30am 11th of
October (UK time) via the following link:
https://stream.brrmedia.co.uk/broadcast/67068e9c5c401b3f38830f49
To ask questions, you must dial in
via conference line using the below details:
·
Confirmation password: THG Q3
·
UK dial in: +44 (0) 33 0551 0200
· US
dial in: +1 786 697 3501
For
further information please contact:
Investor enquiries - THG PLC
|
|
|
Greg Feehely, SVP Investor
Relations
Kate Grimoldby, Director of Investor
Relations and Strategic Projects
|
Investor.Relations@thg.com
|
|
Media enquiries:
|
|
|
Sodali & Co - Financial PR adviser
|
Tel: +44 (0) 20 7250 1446
|
|
Victoria Palmer-Moore / Russ
Lynch
|
thg@sodali.com
|
|
THG
PLC
Viki Tahmasebi
|
Viki.tahmasebi@thg.com
|
|
APPENDIX
Quarterly reported revenue growth rates
|
Q1 2023
|
Q2 2023
|
Q3 2023
|
Q4 2023
|
FY 2023
|
Q1 2024
|
Q2 2024
|
Q3 2024
|
YTD 2024
|
THG Beauty
|
-9.8%
|
-8.3%
|
-1.6%
|
+1.4%
|
-4.1%
|
+11.4%
|
+2.6%
|
+2.3%
|
+5.2%
|
THG Nutrition
|
+5.7%
|
+1.8%
|
-3.8%
|
-6.0%
|
-0.7%
|
-9.0%
|
-12.8%
|
-13.1%
|
-11.6%
|
THG Ingenuity
|
-14.3%
|
-15.4%
|
-8.8%
|
-5.8%
|
-11.0%
|
-5.3%
|
-3.6%
|
-8.2%
|
-5.7%
|
Inter-group elimination
|
-15.5%
|
-17.1%
|
-10.5%
|
-9.0%
|
-13.0%
|
-8.0%
|
10.6%
|
-15.7%
|
-11.4%
|
Group (continuing) revenue
|
-4.4%
|
-4.9%
|
-2.5%
|
-0.5%
|
-2.9%
|
+2.9%
|
-1.6%
|
-2.0%
|
-0.3%
|
Other (discontinued)
|
-38.1%
|
-48.5%
|
-60.1%
|
-53.0%
|
-50.0%
|
-54.8%
|
54.1%
|
-61.3%
|
-56.2%
|
Group revenue
|
-8.3%
|
-10.3%
|
-9.5%
|
-6.9%
|
-8.7%
|
-2.0%
|
-5.2%
|
-5.2%
|
-4.1%
|
Memo: External Ingenuity
|
-10.1%
|
-8.6%
|
-2.9%
|
+7.1%
|
-3.5%
|
+4.1%
|
+21.2%
|
+15.0%
|
+13.5%
|
Quarterly
constant currency revenue growth rates
|
Q1 2023
|
Q2 2023
|
Q3 2023
|
Q4 2023
|
FY 2023
|
Q1 2024
|
Q2 2024
|
Q3 2024
|
YTD 2024
|
THG
Beauty
|
-12.9%
|
-8.5%
|
0.9%
|
+3.2%
|
-3.9%
|
+13.2%
|
+3.2%
|
+2.8%
|
+7.3%
|
THG
Nutrition
|
+3.8%
|
+2.0%
|
-1.4%
|
-4.0%
|
0.0%
|
-5.8%
|
-9.2%
|
-10.5%
|
-7.4%
|
THG
Ingenuity
|
-14.7%
|
-15.4%
|
-8.5%
|
-5.4%
|
-10.9%
|
-4.9%
|
-3.5%
|
-8.0%
|
-5.2%
|
Inter-group elimination
|
-15.5%
|
-17.1%
|
-10.5%
|
-9.0%
|
-13.0%
|
-8.0%
|
-10.6%
|
-15.7%
|
-11.4%
|
Group (continuing)
revenue
|
-7.1%
|
-5.0%
|
-0.1%
|
+1.5%
|
-2.5%
|
+5.3%
|
+0.2%
|
-0.6%
|
+2.7%
|
Other
(discontinued)
|
-37.7%
|
-48.5%
|
-59.9%
|
-52.9%
|
-49.9%
|
-53.9%
|
-53.7%
|
-61.0%
|
-55.3%
|
Group
revenue
|
-11.0%
|
-10.1%
|
-7.6%
|
-5.3%
|
-8.4%
|
+0.3%
|
-3.4%
|
-3.9%
|
-1.3%
|
Memo:
External Ingenuity
|
-11.7%
|
-8.8%
|
-1.4%
|
+9.4%
|
-3.1%
|
+5.9%
|
+22.3%
|
+16.0%
|
+16.0%
|
Quarterly reported revenue
£m
|
Q1
2023
|
Q2
2023
|
Q3
2023
|
Q4
2023
|
FY
2023
|
Q1
2024
|
Q2
2024
|
Q3
2024
|
YTD
2024
|
THG Beauty
|
227.9
|
259.6
|
249.0
|
360.3
|
1,096.9
|
253.9
|
266.3
|
254.7
|
775.0
|
THG Nutrition
|
165.7
|
171.0
|
154.8
|
166.4
|
657.9
|
150.8
|
149.0
|
134.5
|
434.3
|
THG Ingenuity (external)
|
35.6
|
35.6
|
38.2
|
44.6
|
154.0
|
37.0
|
43.2
|
44.0
|
124.2
|
Group (continuing)
revenue
|
429.2
|
466.2
|
442.1
|
571.4
|
1,908.9
|
441.8
|
458.6
|
433.1
|
1,333.5
|
Discontinued revenue
|
40.1
|
33.7
|
25.0
|
37.6
|
136.5
|
18.2
|
15.5
|
9.7
|
43.3
|
Total revenue
|
469.4
|
499.9
|
467.2
|
609.0
|
2,045.4
|
459.9
|
474.0
|
442.8
|
1,376.8
|
|
|
|
|
|
|
|
|
|
|
THG Ingenuity (internal)
|
122.3
|
126.5
|
117.4
|
153.6
|
519.9
|
112.6
|
113.0
|
98.9
|
324.6
|
THG Ingenuity total
|
157.9
|
162.1
|
155.7
|
198.2
|
673.9
|
149.6
|
156.2
|
142.9
|
448.7
|
|
|
Above numbers and table subject to rounding.
ENDS
Notes to editors
THG PLC operate three distinct
businesses in Beauty, Nutrition and Ingenuity, each scaled from the
UK to hold global leading positions in their respective
sectors.
Cautionary Statement
Certain statements included within this announcement may
constitute "forward-looking statements" in respect of the group's
operations, performance, prospects and/or financial condition.
Forward-looking statements are sometimes, but not always,
identified by their use of a date in the future or such words and
words of similar meaning as "anticipates", "aims", "due", "could",
"may", "will", "should", "expects", "believes", "intends", "plans",
"potential", "targets", "goal" or "estimates". By their nature,
forward-looking statements involve a number of risks, uncertainties
and assumptions and actual results or events may differ materially
from those expressed or implied by those statements. Accordingly,
no assurance can be given that any particular expectation will be
met and reliance should not be placed on any forward-looking
statement. Additionally, forward-looking statements regarding past
trends or activities should not be taken as a representation that
such trends or activities will continue in the future. No
responsibility or obligation is accepted to update or revise any
forward-looking statement resulting from new information, future
events or otherwise. Nothing in this announcement should be
construed as a profit forecast. This announcement does not
constitute or form part of any offer or invitation to sell, or any
solicitation of any offer to purchase any shares or other
securities in the Company, nor shall it or any part of it or the
fact of its distribution form the basis of, or be relied on in
connection with, any contract or commitment or investment decisions
relating thereto, nor does it constitute a recommendation regarding
the shares or other securities of the Company. Past performance
cannot be relied upon as a guide to future performance and persons
needing advice should consult an independent financial adviser.
Statements in this announcement reflect the knowledge and
information available at the time of its
preparation.